相关实验视频

Updated: Jul 12, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.8K

中枢神经系统预防方法在高风险的扩散性大B细胞淋巴瘤患者:一个追溯收集,单中心队列分析

Yanli Wang1, Xiaolian Wen1, Tao Guan1

  • 1Shanxi Medical University Affiliated Cancer Hospital/Shanxi Provincial Cancer Hospital/Chinese Academy of Medical Sciences Cancer Hospital Affiliated Shanxi Hospital, Hematology Department, Taiyuan, China.

Cancer medicine
|April 1, 2025
PubMed
概括

高剂量甲状腺素 (HD-MTX) 可能有助于预防分散型大B细胞淋巴瘤 (DLBCL) 患者中中枢神经系统 (CNS) 复发. 虽然没有得到确定的证据,但年轻的患者和风险较低的患者显示出潜在的益处,并能很好地容忍治疗.

关键词:
中枢神经系统的预防.中央神经系统的复发扩散的大B细胞淋巴瘤系统性高剂量的甲基甲酸盐.

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.6K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.2K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...